Karine Ryffel, Olivier Péter, Luc Binet, Eric Dayer 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Ticking the right boxes: classification of patients suspected of Lyme borreliosis at an academic referral center in the Netherlands  J. Coumou, E.A. Herkes,
Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Comparison of A60 and three glycolipid antigens in an ELISA test for tuberculosis  Nancy Simonney, Jean Michel Molina, Mathieu Molimard, Eric Oksenhendler,
L. Boyanova  Clinical Microbiology and Infection 
Philippe Brouqui, Didier Raoult, Jean Marc Durand 
Ticking the right boxes: classification of patients suspected of Lyme borreliosis at an academic referral center in the Netherlands  J. Coumou, E.A. Herkes,
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Cross-reaction between Yersinia outer membrane proteins and anti-Borreli antibodies in sera of patients with Lyme disease  E. Golkocheva-Markova, I. Christova,
Migrant health—a cause for concern?
Atypical respiratory pathogens
Association of distinct species of Borrelia burgdorferi sensu lato with neuroborreliosis in Switzerland  Olivier Péter, Anne-Gabrielle Bretz, Danièle.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Immunoenzymatic dot-blot test for the diagnosis of enteric fever caused by Salmonella typhi in an endemic area  Nora Cardona-Castro, Piedad Agudelo-Flórez 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Acrodermatitis chronica atrophicans and serologic confirmation of infection due to Borrelia afzelii and/or Borrelia garinii by immunoblot  Viviane A.
R. Cantón  Clinical Microbiology and Infection 
Hydatid disease Clinical Microbiology and Infection
Successful treatment of Salmonella aortitis with ciprofloxacin
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Non-antibiotic strategies for sepsis
G. Stanek, M. Reiter  Clinical Microbiology and Infection 
Ticking the right boxes: classification of patients suspected of Lyme borreliosis at an academic referral center in the Netherlands  J. Coumou, E.A. Herkes,
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto's thyroiditis  S. Chatzipanagiotou, J.N.
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
Cephalosporins: a pharmacological update
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
M. Roche, H. Humphreys, E. Smyth, J. Phillips, R. Cunney, E
Sepsis and neutropenia induced by clozapine
Uncommon opportunistic fungi: new nosocomial threats
Acrodermatitis chronica atrophicans and serologic confirmation of infection due to Borrelia afzelii and/or Borrelia garinii by immunoblot  Viviane A.
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
Clinical Microbiology and Infection
Community-acquired pneumonia: epidemiologic and clinical consideration
Training in infectious diseases and tropical medicine in Britain
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection  R. Nir-Paz, A. Michael-Gayego, M. Ron, C.
Clinical infection services—the Leiden experience
Statin use and clinical outcomes among pneumonia patients
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis  José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.
Overview of cefixime use in community-acquired infections
S. Alexiou-Daniel, A. Stylianakis, A. Papoutsi, I. Zorbas, A. Papa, A
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
Javier Aznar, Hassan Safi, Maria C. Conejo, José C. Palomares 
D. Baud, C. Kebbi, J.-P. Külling, G. Greub 
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

Interpretation of immunoblots for Lyme borreliosis using a semiquantitative approach  Karine Ryffel, Olivier Péter, Luc Binet, Eric Dayer  Clinical Microbiology and Infection  Volume 4, Issue 4, Pages 205-212 (April 1998) DOI: 10.1111/j.1469-0691.1998.tb00670.x Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Typical immunoblot profiles for the positive controls and for the sera of patients with specific symptoms of Lyme borreliosis: 1, positive control IgG; 2, positive control IgM; 3, patient with arthritis IgG; 4, patient with ACA IgG; 5, patient with neuroborreliosis IgG; 6, patient with neuroborreliosis Igh4; 7, patient with erythema migrans IgG; 8, patient with erythema migrans IgM. Protein bands with molecular masses of 93, 83, 75, 66, 60, 55, 46, 41, 39, 37, 32.5, 30, 28, 22 and 18 kDa are regularly detected by the positive IgG control. Protein bands with molecular masses of 93, 60, 41, 37, 32.5 and 22–23 kDa were regularly detected by the positive IgM control. Clinical Microbiology and Infection 1998 4, 205-212DOI: (10.1111/j.1469-0691.1998.tb00670.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions